You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Medtronic
Colorcon
Merck
McKinsey

Last Updated: April 15, 2021

DrugPatentWatch Database Preview

DrugPatentWatch Database Updates: New Patent Delistings

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

DrugPatentWatch Database Updates: New Patent Delistings

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Usecode Patented / Exclusive Use
Allergan COMBIGAN brimonidine tartrate; timolol maleate SOLUTION/DROPS 021398 Oct 30, 2007 RX Yes   Start Trial   Start Trial
Cubist Pharms ENTEREG alvimopan CAPSULE 021775 May 20, 2008 RX Yes   Start Trial   Start Trial U-1443 ACCELERATING THE TIME TO UPPER AND LOWER GASTROINTESTINAL RECOVERY FOLLOWING SURGERIES THAT INCLUDE PARTIAL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS
Cubist Pharms ENTEREG alvimopan CAPSULE 021775 May 20, 2008 RX Yes   Start Trial   Start Trial U-1485 TREATING A SUBJECT UNDERGOING ABDOMINAL SURGERY BY ADMINISTERING ALVIMOPAN TO ACCELERATE THE TIME TO UPPER AND LOWER GASTROINTESTINAL RECOVERY FOLLOWING SURGERIES THAT INCLUDE PARTIAL BOWEL RESECTION WITH PRIMARY ANASTOMOSIS
Recordati Rare NEOPROFEN ibuprofen lysine INJECTABLE 021903 Apr 13, 2006 RX Yes   Start Trial   Start Trial U-794 CLOSURE OF A CLINICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS IN PREMATURE INFANTS WEIGHING BETWEEN 500 AND 1500G, WHO ARE NO MORE THAN 32 WEEKS GESTATIONAL AGE WHEN USUAL MEDICAL MANAGEMENT IS INEFFECTIVE
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE 022272 Apr 5, 2010 RX Yes   Start Trial   Start Trial
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE 022272 Apr 5, 2010 RX Yes   Start Trial   Start Trial
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE 022272 Apr 5, 2010 RX Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Patent Expiration >Usecode >Patented / Exclusive Use

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Medtronic
Merck
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.